Gender differences with short-term vs 12 months dual antiplatelet therapy in patients with acute coronary syndrome treated with the COMBO dual therapy stent: 2-years follow-up results of the REDUCE trial

Background Gender differences in the thrombotic and bleeding risk have been suggested to condition the benefits of antithrombotic therapies in Acute Coronary Syndrome (ACS) patients, and mainly among those undergoing percutaneous coronary interventions with drug eluting stents (DES). The impact of g...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of thrombosis and thrombolysis 2021-10, Vol.52 (3), p.797-807
Hauptverfasser:	Verdoia, M., Suryapranata, H., Damen, S., Camaro, C., Benit, E., Barbieri, L., Rasoul, S., Liew, H. B., Polad, J., Ahmad, W. A. W., Zambahari, R., Lalmand, J., van der Schaaf, R. J., Koh, T. H., Timmermans, P, Dilling-Boer, D., Veenstra, L. F., van’t Hof, A. W. J., Lee, S. W. L., Roolvink, V., Ligtenberg, E., Postma, S., Kolkman, E. J. J., Brouwer, M. A., Kedhi, E., De Luca, G.
Format:	Artikel
Sprache:	eng
Schlagworte:	Acute Coronary Syndrome - drug therapy Acute coronary syndromes Antiplatelet therapy Bleeding Blood pressure Cardiology Cardiovascular diseases Cerebral infarction Drug delivery Drug Therapy, Combination Female Females Follow-Up Studies Gender Gender differences Hematology Hemorrhage - chemically induced Humans Implants Male Males Medicine Medicine & Public Health Mortality Myocardial infarction Patients Percutaneous Coronary Intervention Platelet Aggregation Inhibitors - therapeutic use Prospective Studies Sex differences Sex Factors Stents Stroke Thrombosis Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!